Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02477800
Brief Title: 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (ENGAGE)

First Submitted : June 18, 2015
First Submitted that Met QC Criteria : June 18, 2015
First Posted : June 23, 2015 (Estimate)

Certification/Extension First Submitted : August 7, 2020
Certification/Extension First Submitted that Met QC Criteria : August 7, 2020
Certification/Extension First Posted : August 14, 2020

Last Update Submitted that Met QC Criteria : August 7, 2020
Last Update Posted : August 14, 2020